Tumor microenvironment and immune-related therapies of head and neck squamous cell carcinoma - ScienceDirect
Advantages of targeting the tumor immune microenvironment over blocking immune checkpoint in cancer immunotherapy | Signal Transduction and Targeted Therapy
Immunogenic cell death and its therapeutic or prognostic potential in high-grade glioma | Genes & Immunity
Frontiers | Therapeutic strategies for gastric cancer targeting immune cells: Future directions
Frontiers | Sensing Soluble Immune Checkpoint Molecules and Disease-Relevant Cytokines in Cancer: A Novel Paradigm in Disease Diagnosis and Monitoring
Cancer immunology - Wikipedia
Current Oncology | Free Full-Text | Current and Future Biomarkers for Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinoma
Reprogramming the anti-tumor immune response via CRISPR genetic and epigenetic editing: Molecular Therapy - Methods & Clinical Development
Cancers | Free Full-Text | Immunotherapy Predictive Molecular Markers in Advanced Gastroesophageal Cancer: MSI and Beyond
Cancers | Free Full-Text | Immune Checkpoint and Other Receptor-Ligand Pairs Modulating Macrophages in Cancer: Present and Prospects
T follicular helper cells in cancer: Trends in Cancer
Frontiers | The Crosstalk Between Tumor Cells and the Immune Microenvironment in Breast Cancer: Implications for Immunotherapy
What Are Immune Checkpoints?
Cancers | Free Full-Text | NSC243928 Treatment Induces Anti-Tumor Immune Response in Mouse Mammary Tumor Models
Immune Checkpoint Inhibitor Therapy in Oncology: Current Uses and Future Directions: JACC: CardioOncology State-of-the-Art Review | JACC: CardioOncology
Frontiers | The Mechanism of Stimulating and Mobilizing the Immune System Enhancing the Anti-Tumor Immunity
Nanoparticle-Based Immunotherapy for Cancer | ACS Nano
Systemic immunity in cancer | Nature Reviews Cancer
Laboratory biomarkers of an effective antitumor immune response. Clinical significance. - ScienceDirect
Cells | Free Full-Text | The Immune Privilege of Cancer Stem Cells: A Key to Understanding Tumor Immune Escape and Therapy Failure
